Skip to main content

Advertisement

Table 3 Characteristics of breast cancers diagnosed from 2004 to 2005 by the method of detection (screening vs. clinical)

From: HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005

  Proportion detected by screening mammography (%) Pvalue
All patients * 196/587 (33.4%) -
HER-2 negative 180/516 (34.9%)  
HER-2 positive 16/71 (22.5%) 0.039
ER positive 191/536 (35.6%)  
ER negative 5/51 (9.8%) < 0.0001
PR positive 171/460 (37.2%)  
PR negative 25/102 (19.7%) < 0.0001
Triple negative 4/32 (12.5%)  
Non-triple negative 192/555 (34.6%) 0.100
  1. * Patients over 50 years old (age group of screening). ER = estrogen receptor; HER2 = human epidermal growth factor receptor 2; PR = progesterone receptor.